Oil and gas sectot may not put up good numbers in Q4.
India Inc will report good set of numbers in Q4.
Most infra projects have hit a road block due to high cost of funds.
Financial advisors say, not to get carried away by stocks that promise high returns in short time.
India has more service companies, such as IT and healthcaresectors, which always trade at a premium to the overall market.
Gold companies have started reducing production. This implies that gold prices will not go on a free fall anytime soon
Ironically, bad loans and non-performing assets are on the rise in public sector banks in India, say sector watchers.
More than half the Sensex companies have declared their results for the third quarter and there are more positive surprises than disappointments.
Analysts say Tatas could sustain their current pace of growth, provided the group's "cash cows", such as TCS and Tata Motors, continue to deliver.
In five years, royalty payments have grown 31.1% yearly, much faster than rise in revenue and profit.
Barring one, three are debt-free and sitting on large cash reserves.
Putting money in key PSUs a better option
No one can fault India Inc for not taking care of shareholders; in fact, it has been extra generous.
Sensex rose 5.8% this year, against a 3.2% rise in Nifty; Axis Bank inclusion may blunt Sensex edge
With uncertainty looming large over Indian markets, retail investors can increase their exposure to US funds.
In January 2008, the Sensex hit then all-time high of 21,207 (closing high of 21,004 was achieved in November 2010).
At its current stock price, RIL now has 8.4 per cent weight in the Sensex against Infosys' 8.8 per cent.
Department seeks investor database on the suspicion of fictitious investors.
For FY14, the first full year of the law's implementation, the spend could go up to nearly Rs 8,700 crore (Rs 87 billion), given that India Inc's profitability has grown at a compounded 7.5 per cent annually in the past three years.
Bigger and broader indices do relatively poorly as investors get selective; experts see opportunity if scrips chosen with care.